Luminex Licenses LabMap to ARUP Laboratories | GenomeWeb

NEW YORK, April 17 – Luminex has licensed its LabMap technology to ARUP Laboratories, a national specialty diagnostic reference laboratory, the company said Tuesday.

Under the agreement, ARUP will use Luminex’s technology to develop clinical laboratory assays for antibodies to common disease agents, such as Streptococcus pneumoniae  and mitogens. Luminex will receive royalties on the sale of these diagnostic tests. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.